NeuroPace, Inc.
NPCE
$10.79
$0.363.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.71% | 27.44% | 15.81% | -43.95% | 14.57% |
| Total Depreciation and Amortization | 0.00% | 1.58% | 4.96% | 3.42% | 2.76% |
| Total Amortization of Deferred Charges | 4.26% | -12.96% | -30.77% | 2.63% | 2.70% |
| Total Other Non-Cash Items | 10.22% | -22.66% | -2.09% | 11.77% | -4.29% |
| Change in Net Operating Assets | -647.99% | 255.68% | 86.70% | -232.83% | -167.83% |
| Cash from Operations | -178.25% | 55.79% | 48.19% | -125.32% | -45.13% |
| Capital Expenditure | 61.00% | -58.73% | 39.42% | -225.00% | -255.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.33% | -54.55% | 32.00% | -28.57% | -16.67% |
| Cash from Investing | 40.07% | -56.75% | 35.10% | -30.91% | -17.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -68.31% | 410.50% | -19.42% | -91.45% | 105,362.50% |
| Repurchase of Common Stock | -35.29% | 5.56% | 88.91% | -1,654.05% | -5.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.74% | 469.35% | 606.94% | -99.12% | 30,522.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.23% | 1,771.43% | 96.96% | -160.66% | 347.96% |